Charles Mount, MD
Dermatology · Pittsburgh, PANPI 1598962078
Payments from drug & device makers
Across 728 payments — averaging $259.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$139K
- Novartis$24K
- Bristol Myers Squibb$12K
- Regeneron Healthcare Solutions, Inc.$3K
- UCB, Inc.$2K
- Johnson & Johnson$2K
- plus $6K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 297 | $139,193 |
| Novartis | 43 | $24,341 |
| Bristol Myers Squibb | 19 | $12,161 |
| Regeneron Healthcare Solutions, Inc. | 18 | $2,818 |
| UCB, Inc. | 28 | $2,179 |
| Johnson & Johnson | 136 | $2,134 |
| Amgen | 3 | $2,032 |
| Galderma Laboratories, L.p. | 59 | $752 |
| Sanofi | 27 | $668 |
| E.r. Squibb & Sons, L.L.C. | 48 | $610 |
| AstraZeneca | 10 | $528 |
| Journey Medical Corporation | 8 | $446 |
| Incyte Corporation | 6 | $220 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $122 |
| Arcutis Biotherapeutics, Inc. | 1 | $112 |
| Kyowa Kirin, Inc. | 1 | $95 |
| Regeneron | 2 | $84 |
| LEO Pharma Inc. | 3 | $78 |
| Sun Pharmaceutical Industries Inc. | 3 | $74 |
| Dermavant Sciences, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $42 |
| Merck | 2 | $37 |
| Janssen Scientific Affairs, LLC | 1 | $31 |
| Pfizer | 2 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| Organon | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
How this compares
$188,943 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Pittsburgh
- Laura FerrisPittsburgh$4.3M
- Joe TungPittsburgh$1.5M
- Oleg AkilovPittsburgh$1.3M
- Neil NirenPittsburgh$574K
- Timothy PattonPittsburgh$276K
- Daniel KaplanPittsburgh$165K
- Hassane ZarourPittsburgh$131K
- Victoria WerthPhiladelphia$7.2M
- Joel GelfandPhiladelphia$3.6M
- Scott GottliebExton$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.